Pablo Sánchez Vela (@sanchezvelamd) 's Twitter Profile
Pablo Sánchez Vela

@sanchezvelamd

Physician-Scientist in the @RossLevineLab at @MSKCancerCenter. @TheMarkFdn Fellow. All these tweets only express my own opinions and not the previous.

ID: 1294741713467179010

calendar_today15-08-2020 21:04:31

98 Tweet

393 Followers

1,1K Following

nature (@nature) 's Twitter Profile Photo

The mood was defiant at many of the rallies, where chants of “Scientists will not be silenced”, “Facts over fear” and “What do we want? Peer review! When do we want it? Now!” were heard. go.nature.com/43rWyFG

richard white (@whitefishlab) 's Twitter Profile Photo

Stromal mutations occur, but hard to prove they are functional. In our new paper with Trey Ideker’s lab and led by Dr. Mohita Tagore and Maayan Baron, we show that we can find these by looking for mutations across a “class” of genes rather than single genes: nature.com/articles/s4158…

Cancer Discovery (@cd_aacr) 's Twitter Profile Photo

Chairperson Manel Esteller is discussing the Epigenetic Hallmarks of Cancer now at the #AACR25 Education Session on the Evolution of Cancer Hallmarks - read the landmark review: brnw.ch/21wSeP3

Chairperson <a href="/ManelEsteller/">Manel Esteller</a> is discussing the Epigenetic Hallmarks of Cancer now at the #AACR25 Education Session on the Evolution of Cancer Hallmarks - read the landmark review: brnw.ch/21wSeP3
MSK Department of Medicine (@msk_deptofmed) 's Twitter Profile Photo

Don't miss posters at #AACR25 starting now! Pablo Sánchez Vela will present a study that evaluated Tet2-mutant clonal hematopoiesis microenvironment enrichment as a driver of treatment resistance in #thyroidcancer. Memorial Sloan Kettering Cancer Center ASCO Learn more: bit.ly/4lXQUSL

Don't miss posters at #AACR25 starting now! <a href="/sanchezvelamd/">Pablo Sánchez Vela</a> will present a study that evaluated Tet2-mutant clonal hematopoiesis microenvironment enrichment as a driver of treatment resistance in #thyroidcancer. <a href="/MSKCancerCenter/">Memorial Sloan Kettering Cancer Center</a> <a href="/ASCO/">ASCO</a> 

Learn more: bit.ly/4lXQUSL
Memorial Sloan Kettering Cancer Center (@mskcancercenter) 's Twitter Profile Photo

🚨 New research from MSK and Weill Cornell Medicine shows that BCG, the first FDA-approved cancer #immunotherapy, doesn't just act locally in the bladder. It travels to the bone marrow, where it reprograms and amplifies immune stem cells, boosting the body’s ability to fight cancer more

🚨 New research from MSK and <a href="/WeillCornell/">Weill Cornell Medicine</a> shows that BCG, the first FDA-approved cancer #immunotherapy, doesn't just act locally in the bladder. It travels to the bone marrow, where it reprograms and amplifies immune stem cells, boosting the body’s ability to fight cancer more
AACR Foundation (@aacrfoundation) 's Twitter Profile Photo

What is cancer research? Learn about the cycle of cancer research and the different types of cancer science, including basic, translational, clinical, and population research. brnw.ch/21wTZMB

What is cancer research? Learn about the cycle of cancer research and the different types of cancer science, including basic, translational, clinical, and population research. brnw.ch/21wTZMB
nature (@nature) 's Twitter Profile Photo

Nature research paper: Immigrant–native pay gap driven by lack of access to high-paying jobs go.nature.com/46bysR5

RUNX1 Research Program (@runx1research) 's Twitter Profile Photo

We’re proud to partner with American Cancer Society to announce the recipients of the inaugural Leukemia Exploration And Prevention (LEAP) Team Grant. 𝘗𝘳𝘰𝘫𝘦𝘤𝘵: 𝘐𝘯𝘵𝘳𝘪𝘯𝘴𝘪𝘤 & 𝘦𝘹𝘵𝘳𝘪𝘯𝘴𝘪𝘤 𝘮𝘦𝘤𝘩𝘢𝘯𝘪𝘴𝘮𝘴 𝘥𝘳𝘪𝘷𝘪𝘯𝘨 𝘤𝘭𝘰𝘯𝘢𝘭 𝘧𝘪𝘵𝘯𝘦𝘴𝘴 𝘢𝘯𝘥

We’re proud to partner with <a href="/AmericanCancer/">American Cancer Society</a> to announce the recipients of the inaugural Leukemia Exploration And Prevention (LEAP) Team Grant.

𝘗𝘳𝘰𝘫𝘦𝘤𝘵: 𝘐𝘯𝘵𝘳𝘪𝘯𝘴𝘪𝘤 &amp; 𝘦𝘹𝘵𝘳𝘪𝘯𝘴𝘪𝘤 𝘮𝘦𝘤𝘩𝘢𝘯𝘪𝘴𝘮𝘴 𝘥𝘳𝘪𝘷𝘪𝘯𝘨 𝘤𝘭𝘰𝘯𝘢𝘭 𝘧𝘪𝘵𝘯𝘦𝘴𝘴 𝘢𝘯𝘥
Memorial Sloan Kettering Cancer Center (@mskcancercenter) 's Twitter Profile Photo

Dr. Ross Levine (Ross Levine), Senior Vice President of Translational Research at MSK, has been named MSK's new Chief Scientific Officer (CSO). Dr. Levine will be responsible for setting and leading strategy for basic and translational research, including programs, centers,

Dr. Ross Levine (<a href="/rosslevinemd/">Ross Levine</a>), Senior Vice President of Translational Research at MSK, has been named MSK's new Chief Scientific Officer (CSO). 

Dr. Levine will be responsible for setting and leading strategy for basic and translational research, including programs, centers,
Cell Press (@cellpressnews) 's Twitter Profile Photo

Researchers from Memorial Sloan Kettering Cancer Center have developed a proximity-tagging method to map molecules that associate in 3D space to better understand chromatin organization. Read more in @molecularcell #ASHG25 hubs.li/Q03P9XQm0

Journal of Clinical Investigation (@jclinicalinvest) 's Twitter Profile Photo

Little progress has been made in the treatment of anaplastic thyroid cancer Vera Tiedje Gnana Krishnamoorthy et al. Memorial Sloan Kettering Cancer Center now find mice with aggressive ATC respond to the inhibitor combination dabrafenib/trametinib by affecting cancer cell MHCII expression & increasing T-cell

Little progress has been made in the treatment of anaplastic thyroid cancer

<a href="/VeraTiedje/">Vera Tiedje</a> <a href="/Gnana_Krish/">Gnana Krishnamoorthy</a> et al. <a href="/MSKCancerCenter/">Memorial Sloan Kettering Cancer Center</a> now find mice with aggressive ATC respond to the inhibitor combination dabrafenib/trametinib by affecting cancer cell MHCII expression &amp; increasing T-cell